Design, synthesis, and biological evaluation of a series of benzofuran[3,2-d]pyrimidine-4(3H)-one derivatives containing thiosemicarbazone analogs as novel PARP-1 inhibitors-Reference-Cited by-同舟云学术

Design, synthesis, and biological evaluation of a series of benzofuran[3,2-d]pyrimidine-4(3H)-one derivatives containing thiosemicarbazone analogs as novel PARP-1 inhibitors

Published:2023-10 Issue: Volume:139 Page:106759
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Wang Yuanjiang,Li Kun,Xu Wenqing,Gou Shaohua^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference29 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. Specific killing of BRCA2-deficient tumors with inhibitors of poly (ADP-ribose) polymerase;Bryant;Nature,2005

3. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy;Farmer;Nature,2005

4. Discovery of novel bromophenol-thiosemicarbazone hybrids as potent selective inhibitors of poly(ADP-ribose) polymerase-1 (PARP- for Use in cancer;Guo;J. Med. Chem.,2019

5. Comparative study of the mode of action of clinically approved platinum-based chemotherapeutics;Schoch;Int. J. Mol. Sci.,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on small molecule compounds targeting synthetic lethality for cancer therapy;European Journal of Medicinal Chemistry;2024-11

2. Targeting selective inhibitors of PARPs in drug discovery and development;Medicinal Chemistry Research;2024-07-28

3. Leveraging shape screening and molecular dynamics simulations to optimize PARP1-Specific chemo/radio-potentiators for antitumor drug design;Archives of Biochemistry and Biophysics;2024-06

4. Pirimidin Halkası İçeren ONS Tridentat Schiff Baz Ligand ve Cu(II), Co(II) ve Pt(IV) Komplekslerinin Sentezi, Karakterizasyonu ve Termal Çalışmaları;Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi;2024-03-01

5. Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets;Pharmacology & Therapeutics;2024-02